Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2010
Total Assets: $1.77B
Liabilities Breakdown FY2010
Total Liabilities: $459.0M
Asset Breakdown
Total Assets: $1.77B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $396.1M | 22.4% |
| Accounts Receivable | $277.3M | 15.7% |
| Inventory | $203.6M | 11.5% |
| Property, Plant & Equipment | $269.8M | 15.3% |
| Goodwill | $315.2M | 17.8% |
| Intangible Assets | $67.1M | 3.8% |
| Other Assets | $238.1M | 13.5% |
Liabilities Breakdown
Total Liabilities: $459.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $47.6M | 10.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $411.4M | 89.6% |